BRAF and congenital mesoblastic nephroma: While on the other hand, the histopathological features of a CMN can provide relevant information on its molecular background, including the presence of BRAF V600E gene mutation, which is the most common driver of melanocytic tumors and the most common therapeutically targetable alteration in melanoma.